Cargando…

Medicare Spending on Drugs With Accelerated Approval, 2015-2019

This article examines the budgetary implications of high-priced accelerated approval drugs by estimating Medicare spending on these drugs from 2015 through 2019.

Detalles Bibliográficos
Autores principales: Rome, Benjamin N., Feldman, William B., Kesselheim, Aaron S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796889/
https://www.ncbi.nlm.nih.gov/pubmed/35977299
http://dx.doi.org/10.1001/jamahealthforum.2021.3937
_version_ 1784641416557756416
author Rome, Benjamin N.
Feldman, William B.
Kesselheim, Aaron S.
author_facet Rome, Benjamin N.
Feldman, William B.
Kesselheim, Aaron S.
author_sort Rome, Benjamin N.
collection PubMed
description This article examines the budgetary implications of high-priced accelerated approval drugs by estimating Medicare spending on these drugs from 2015 through 2019.
format Online
Article
Text
id pubmed-8796889
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-87968892022-02-07 Medicare Spending on Drugs With Accelerated Approval, 2015-2019 Rome, Benjamin N. Feldman, William B. Kesselheim, Aaron S. JAMA Health Forum Research Letter This article examines the budgetary implications of high-priced accelerated approval drugs by estimating Medicare spending on these drugs from 2015 through 2019. American Medical Association 2021-12-03 /pmc/articles/PMC8796889/ /pubmed/35977299 http://dx.doi.org/10.1001/jamahealthforum.2021.3937 Text en Copyright 2021 Rome BN et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Research Letter
Rome, Benjamin N.
Feldman, William B.
Kesselheim, Aaron S.
Medicare Spending on Drugs With Accelerated Approval, 2015-2019
title Medicare Spending on Drugs With Accelerated Approval, 2015-2019
title_full Medicare Spending on Drugs With Accelerated Approval, 2015-2019
title_fullStr Medicare Spending on Drugs With Accelerated Approval, 2015-2019
title_full_unstemmed Medicare Spending on Drugs With Accelerated Approval, 2015-2019
title_short Medicare Spending on Drugs With Accelerated Approval, 2015-2019
title_sort medicare spending on drugs with accelerated approval, 2015-2019
topic Research Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796889/
https://www.ncbi.nlm.nih.gov/pubmed/35977299
http://dx.doi.org/10.1001/jamahealthforum.2021.3937
work_keys_str_mv AT romebenjaminn medicarespendingondrugswithacceleratedapproval20152019
AT feldmanwilliamb medicarespendingondrugswithacceleratedapproval20152019
AT kesselheimaarons medicarespendingondrugswithacceleratedapproval20152019